Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Relapsing-Remitting

Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.

455 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis, Relapsing-Remitting trial results

Recruiting

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

NCT06408259

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Local Institution - 0114 Loma Linda, California, United States
  • University of California Davis Health Sacramento, California, United States
  • University of South Florida Tampa, Florida, United States
  • Local Institution - 0093 Chicago, Illinois, United States
View all 33 locations
View Trial Details
Recruiting

RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis.

NCT05758831

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Hospices Civils de Lyon Hôpital Neurologique Pierre Wertheimer Lyon, Bron, France
  • CHRU de Brest - Hôpital la Cavale Blanche Brest, France
  • Centre Hospitalier Universitaire de Caen Caen, France
  • Centre Hospitalier de Pontoise - GHT NOVO Cergy-Pontoise, France
View all 23 locations
View Trial Details

Related conditions